These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8101413

  • 21. [The treatment of Parkinson's disease].
    Baumann CR, Waldvogel D.
    Praxis (Bern 1994); 2013 Dec 11; 102(25):1529-35. PubMed ID: 24326048
    [Abstract] [Full Text] [Related]

  • 22. [Drug therapy of Parkinson's disease].
    Myllylä V.
    Duodecim; 1997 Dec 11; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract] [Full Text] [Related]

  • 23. [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease].
    Woitalla D, Krüger R, Lorenzl S, Müller T, Oelwein G, Storch A, Wolz M, Wüllner U.
    Fortschr Neurol Psychiatr; 2020 Sep 11; 88(9):620-633. PubMed ID: 32588409
    [Abstract] [Full Text] [Related]

  • 24. Safinamide for the treatment of Parkinson's disease.
    Kandadai RM, Jabeen SA, Kanikannan MA, Borgohain R.
    Expert Rev Clin Pharmacol; 2014 Nov 11; 7(6):747-59. PubMed ID: 25300164
    [Abstract] [Full Text] [Related]

  • 25. New treatments for the motor symptoms of Parkinson's disease.
    Vijverman AC, Fox SH.
    Expert Rev Clin Pharmacol; 2014 Nov 11; 7(6):761-77. PubMed ID: 25318835
    [Abstract] [Full Text] [Related]

  • 26. Inhibitors of dopamine inactivating systems as antiparkinson drugs.
    Youdim MB.
    Adv Neurol; 1990 Nov 11; 53():483-8. PubMed ID: 2239488
    [No Abstract] [Full Text] [Related]

  • 27. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T.
    Nervenarzt; 2003 Mar 11; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [Abstract] [Full Text] [Related]

  • 28. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK.
    Arch Neurobiol (Madr); 1991 Mar 11; 54(6):282-7. PubMed ID: 1687430
    [No Abstract] [Full Text] [Related]

  • 29. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C, Schumacher HC, Burgut FT.
    Expert Rev Neurother; 2005 Nov 11; 5(6):811-21. PubMed ID: 16274338
    [Abstract] [Full Text] [Related]

  • 30. Future therapies for Parkinson's disease.
    Hauser RA, Lyons KE.
    Neurol Clin; 2004 Oct 11; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract] [Full Text] [Related]

  • 31. Myths and realities of continuous dopaminergic stimulation.
    Pirtošek Z.
    Psychiatr Danub; 2011 Mar 11; 23(1):80-3. PubMed ID: 21448103
    [Abstract] [Full Text] [Related]

  • 32. Drugs for Parkinson's disease.
    Cranwell-Bruce LA.
    Medsurg Nurs; 2010 Mar 11; 19(6):347-9, 355; quiz 350. PubMed ID: 21337993
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.